Skip to main navigation Skip to search Skip to main content

Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles

  • Claudio Cabello-Verrugio*
  • , María Gabriela Morales
  • , Daniel Cabrera
  • , Carlos P. Vio
  • , Enrique Brandan
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Fingerprint

Dive into the research topics of 'Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology